HARROW, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.89 USD | +0.78% |
|
+39.56% | +50.40% |
| May. 15 | B. Riley Raises Price Target on Harrow Health to $29 From $26, Keeps Buy Rating | MT |
| May. 14 | Transcript : Harrow, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Chart calendar Harrow, Inc.
e3463cd25df67685b2286811.twG-ERYqKAZbFGdd0GdCHH0LV4sZM4MVTyyj0Jq5Xqc.1ErVJVcYRGouUzATnQMwTVBMHMZ9e-gkJGbJqMjSAebVYOdGQGBBXm5fBA~27e97f4d36f13b7993496b8c68ac7f6c
Upcoming events on Harrow, Inc.
Past events on Harrow, Inc.
| 2024-05-14 08:00 am | Q1 2024 Earnings Call |
| 2024-05-13 04:01 pm | Q1 2024 Earnings Release |
| 2024-03-20 08:00 am | Q4 2023 Earnings Call |
| 2024-03-19 05:45 pm | Q4 2023 Earnings Release |
| 2023-11-30 08:00 am | Piper Sandler Healthcare Conference |
| 2023-11-27 01:30 pm | BTIG Ophthalmology Day |
| 2023-11-13 04:45 pm | Q3 2023 Earnings Call |
| 2023-11-13 04:01 pm | Q3 2023 Earnings Release |
| 2023-08-09 04:45 pm | Q2 2023 Earnings Call |
| 2023-08-09 04:01 pm | Q2 2023 Earnings Release |
| 2023-06-21 09:00 am | Annual General Meeting |
| 2023-05-24 12:00 pm | B. Riley Securities Institutional Investor Conference |
| 2023-05-11 04:45 pm | Q1 2023 Earnings Call |
| 2023-05-11 04:01 pm | Q1 2023 Earnings Release |
| 2023-03-23 04:45 pm | Q4 2022 Earnings Call |
| 2023-03-23 04:06 pm | Q4 2022 Earnings Release |
| 2022-11-14 04:45 pm | Q3 2022 Earnings Call |
| 2022-11-14 04:05 pm | Q3 2022 Earnings Release |
| 2022-09-29 | American Academy of Ophthalmology Eyecelerator Conference |
| 2022-08-17 07:00 am | H.C. Wainwright & Co. Ophthalmology Virtual Conference - Pre-recorded |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 51,2 52,2 -2.07% | 48,9 48,7 0.28% | 72,5 71,6 1.16% | 88,6 89,8 -1.38% | 130 132 -1.13% | 181 |
|
EBITDA Million USD | Released Forecast Spread | 4,58 4,20 9.05% | 5,72 3,20 78.54% | 19,5 20,7 -5.79% | 13,0 11,7 11.26% | 28,1 37,9 -25.76% | 35,4 |
|
EBIT Million USD | Released Forecast Spread | -4,80 -4,97 3.36% | 0,39 -1,89 120.4% | 1,61 4,24 -61.92% | 1,92 2,45 -21.64% | 0,43 9,24 -95.34% | 3,44 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -0,13 -1,39 90.97% | -3,42 -3,60 5.17% | -17,9 -11,5 -54.93% | -14,0 -13,2 -6.37% | -23,7 -15,4 -53.52% | -17,8 |
|
Net income Million USD | Released Forecast Spread | 0,17 -1,08 115.51% | -3,36 -3,49 3.71% | -18,5 -12,0 -54.13% | -14,1 -14,0 -0.56% | -24,4 -16,8 -45.08% | -19,2 |
|
EPS USD | Released Forecast Spread | 0,01 -0,05 122.22% | -0,13 -0,14 3.7% | -0,69 -0,44 -57.71% | -0,51 -0,67 24.26% | -0,75 -0,52 -45.16% | -0,54 |
| Announcement Date | 13/03/20 | 08/03/21 | 10/03/22 | 23/03/23 | 19/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 22,1 19,5 13.53% | 23,3 22,1 5.66% | 22,8 23,1 -1.36% | 20,3 21,7 -6.45% | 26,1 25,1 3.81% | 33,5 31,0 7.82% | 34,3 37,6 -8.83% | 36,4 37,9 -3.97% | 34,6 36,3 -4.77% | 42,4 | 49,0 | 56,2 | 53,9 | 61,0 |
|
EBITDA Million USD | Released Forecast Spread | 4,94 3,10 59.35% | 4,51 2,90 55.34% | -1,02 3,40 -130.03% | 1,09 -0,20 644.5% | 5,34 6,25 -14.53% | 11,0 9,36 17.61% | 9,21 12,7 -27.77% | 2,56 12,3 -79.17% | 0,23 3,26 -93.04% | 5,91 | 11,4 | 16,8 | 10,8 | 16,8 |
|
EBIT Million USD | Released Forecast Spread | 2,10 1,23 70.63% | 1,69 1,86 -9.04% | -0,09 1,62 -105.81% | -1,78 -0,46 -283.74% | 1,21 2,02 -40.03% | 2,35 4,37 -46.12% | 1,74 6,98 -75% | -4,88 3,94 -223.7% | -6,93 -3,03 -128.65% | -1,68 | 4,41 | 8,03 | 3,67 | 9,20 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,44 -0,84 -188.86% | -6,20 -0,17 -3476.41% | -6,43 -0,42 -1434.37% | 1,06 -4,29 124.62% | -6,93 -1,36 -408.76% | -4,24 -1,23 -244.57% | -2,85 1,18 -341.49% | -9,68 -1,39 -595.78% | -13,6 -8,02 -69.12% | -6,97 | -0,85 | 2,82 | -1,12 | 4,45 |
|
Net income Million USD | Released Forecast Spread | -2,44 -1,32 -85.26% | -6,24 -0,17 -3499.49% | -6,46 -0,07 -8754.79% | 1,06 -3,24 132.53% | -6,64 -1,61 -312.95% | -4,23 -1,24 -241.69% | -4,39 1,18 -472.75% | -9,15 -1,55 -489.43% | -13,6 -7,89 -71.96% | -6,51 | -1,24 | 2,12 | -1,29 | 3,03 |
|
EPS USD | Released Forecast Spread | -0,09 -0,03 -170.03% | -0,23 -0,01 -3348.28% | -0,24 -0,01 -4700% | 0,04 -0,12 134.28% | -0,22 -0,05 -312.53% | -0,14 -0,04 -250% | -0,13 0,04 -454.51% | -0,26 -0,04 -500.05% | -0,38 -0,22 -76.74% | -0,20 | -0,06 | 0,09 | -0,04 | 0,09 |
| Announcement Date | 05/05/22 | 09/08/22 | 14/11/22 | 23/03/23 | 11/05/23 | 09/08/23 | 13/11/23 | 19/03/24 | 13/05/24 | - | - | - | - | - |
More events
Past sector events for Harrow, Inc.
| Today | TARO PHARMACEUTICAL INDUSTRIES LTD.: Q4 2024 Earnings Release |
| 2024-05-17 08:52 am | J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-17 04:28 am | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-15 10:05 am | MANKIND PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-15 01:30 am | DERMAPHARM HOLDING SE: Q1 2024 Earnings Release |
| 2024-05-15 07:40 am | CRESCO LABS INC.: Q1 2024 Earnings Release |
| 2024-05-15 03:03 am | GRANULES INDIA LIMITED: Q4 2024 Earnings Release |
| 2024-05-14 | EISAI CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-14 05:43 pm | LIQUIDIA CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 04:52 am | BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HROW Stock
- Calendar Harrow, Inc.
